Overview

Observational Prospective Study on Patients Treated With Norditropin®

Status:
Completed
Trial end date:
2016-12-31
Target enrollment:
Participant gender:
Summary
This observational study is conducted globally. The aim of the study is to investigate the effectiveness and safety of real-life treatment with Norditropin®. The study population will consist of children and adults who are on treatment with Norditropin® in accordance with normal clinical practice.
Details
Lead Sponsor:
Novo Nordisk A/S